Lantheus Holdings [LNTH] vs Regencell Bioscience [RGC] Detailed Stock Comparison

Lantheus Holdings

NASDAQ

Regencell Bioscience

NASDAQ

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Lantheus Holdings wins in 8 metrics, Regencell Bioscience wins in 4 metrics, with 0 ties. Lantheus Holdings appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Lantheus Holdings	Regencell Bioscience	Better
P/E Ratio (TTM)	14.89	N/A	N/A
Price-to-Book Ratio	3.26	878.57	Lantheus Holdings
Debt-to-Equity Ratio	52.75	0.01	Regencell Bioscience
PEG Ratio	0.51	N/A	N/A
EV/EBITDA	7.54	-1,523.21	Regencell Bioscience
Profit Margin (TTM)	17.82%	0.00%	Lantheus Holdings
Operating Margin (TTM)	23.27%	0.00%	Lantheus Holdings
EBITDA Margin (TTM)	23.27%	N/A	N/A
Return on Equity	24.71%	-47.77%	Lantheus Holdings
Return on Assets (TTM)	13.34%	-30.65%	Lantheus Holdings
Free Cash Flow (TTM)	$465.13M	$-4.01M	Lantheus Holdings
1-Year Return	-44.79%	5,609.09%	Regencell Bioscience
Price-to-Sales Ratio (TTM)	2.50	N/A	N/A
Enterprise Value	$3.73B	$6.08B	Regencell Bioscience
EV/Revenue Ratio	2.45	N/A	N/A
Gross Profit Margin (TTM)	63.75%	N/A	N/A
Revenue per Share (TTM)	$22	N/A	N/A
Earnings per Share (Diluted)	$3.76	$-0.01	Lantheus Holdings
Beta (Stock Volatility)	0.14	2.19	Lantheus Holdings

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Lantheus Holdings vs Regencell Bioscience Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Lantheus Holdings	-1.56%	8.61%	-17.33%	-21.26%	-24.38%	-33.38%
Regencell Bioscience	1.91%	-1.10%	-12.78%	15.02%	10,366.67%	9,561.54%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Lantheus Holdings	-44.79%	-27.42%	338.55%	776.44%	820.06%	820.06%
Regencell Bioscience	5,609.09%	1,531.17%	4,385.71%	4,385.71%	4,385.71%	4,385.71%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Lantheus Holdings (LNTH): View Full Stock Overview

Regencell Bioscience (RGC): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Lantheus Holdings vs Regencell Bioscience

Metric	LNTH	RGC
Market Information
Market Cap i	$3.81B	$6.08B
Market Cap Category	Mid cap	Mid cap
10 Day Avg. Volume i	3,414,760	222,439
90 Day Avg. Volume i	1,859,730	558,706
Last Close	$58.24	$12.80
52 Week Range	$47.25 - $118.21	$0.09 - $83.60
% from 52W High	-50.73%	-84.69%
All-Time High	$126.89 (Jul 15, 2024)	$950.00 (May 30, 2025)
% from All-Time High	-54.10%	-98.65%
Growth Metrics
Quarterly Revenue Growth	-0.04%	N/A
Quarterly Earnings Growth	0.27%	N/A
Financial Health
Profit Margin (TTM) i	0.18%	0.00%
Operating Margin (TTM) i	0.23%	0.00%
Return on Equity (TTM) i	0.25%	-0.48%
Debt to Equity (MRQ) i	52.75	0.01
Cash & Liquidity
Book Value per Share (MRQ)	$17.16	$0.01
Cash per Share (MRQ)	$10.23	N/A
Operating Cash Flow (TTM) i	$527.46M	$-3,881,392
Levered Free Cash Flow (TTM) i	$295.47M	$-4,301,837
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	N/A	N/A

Valuation & Enterprise Metrics Analysis: Lantheus Holdings vs Regencell Bioscience

Metric	LNTH	RGC
Price Ratios
P/E Ratio (TTM) i	14.89	N/A
Forward P/E i	8.08	N/A
PEG Ratio i	0.51	N/A
Price to Sales (TTM) i	2.50	N/A
Price to Book (MRQ) i	3.26	878.57
Market Capitalization
Market Capitalization i	$3.81B	$6.08B
Enterprise Value i	$3.73B	$6.08B
Enterprise Value Metrics
Enterprise to Revenue i	2.45	N/A
Enterprise to EBITDA i	7.54	-1,523.21
Risk & Other Metrics
Beta i	0.14	2.19
Book Value per Share (MRQ) i	$17.16	$0.01

Financial Statements Comparison: Lantheus Holdings vs Regencell Bioscience

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	LNTH	RGC
Revenue/Sales i	$372.76M	N/A
Cost of Goods Sold i	$135.06M	N/A
Gross Profit i	$237.70M	N/A
Research & Development i	$36.31M	N/A
Operating Income (EBIT) i	$106.79M	N/A
EBITDA i	$129.90M	N/A
Pre-Tax Income i	$96.53M	N/A
Income Tax i	$23.58M	N/A
Net Income (Profit) i	$72.95M	N/A

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	LNTH	RGC
Cash & Equivalents i	$938.53M	$2.96M
Total Current Assets i	$1.42B	$8.11M
Total Current Liabilities i	$248.00M	$193,578
Long-Term Debt i	$613.66M	$25,934
Total Shareholders Equity i	$1.16B	$8.22M
Retained Earnings i	$518.89M	$-21.62M
Property, Plant & Equipment i	$0	$84,780

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	LNTH	RGC
Operating Cash Flow i	$95.48M	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	$98.85M	N/A
Debt Repayment i	$-402,000	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	LNTH	RGC
Shares Short i	8.42M	2.25M
Short Ratio i	8.25	1.15
Short % of Float i	0.16%	0.02%
Average Daily Volume (10 Day) i	3,414,760	222,439
Average Daily Volume (90 Day) i	1,859,730	558,706
Shares Outstanding i	68.45M	13.01M
Float Shares i	59.94M	18.43M
% Held by Insiders i	0.02%	0.96%
% Held by Institutions i	1.22%	0.00%

Dividend Analysis & Yield Comparison: Lantheus Holdings vs Regencell Bioscience

Metric	LNTH	RGC
Last 12-Month Dividend i	N/A	N/A
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	N/A	N/A
3-Year Avg Dividend Yield i	N/A	N/A
3-Year Total Dividends i	N/A	N/A
Ex-Dividend Date	N/A	N/A

Lantheus Holdings [LNTH] vs Regencell Bioscience [RGC] Detailed Stock Comparison